This inventor holds 8 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Chiesi Farmaceutici S.p.a., The Medicines Company. Active years: 2014-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2022
Title: The Innovative Contributions of Dawn Bell
Introduction
Dawn Bell is a notable inventor based in Morristown, NJ (US), recognized for her significant contributions to the field of medicine. With a total of 8 patents to her name, she has made strides in improving patient care, particularly in the area of antiplatelet therapy.
Latest Patents
One of her latest patents focuses on the maintenance of platelet inhibition during antiplatelet therapy. This method involves administering cangrelor prior to an invasive procedure to reduce or maintain platelet inhibition in patients. This invention is particularly beneficial for patients in need of antiplatelet therapy or those at risk of thrombosis. Furthermore, it can be utilized in patients who have previously been treated with long-acting platelet inhibitors, all while minimizing the risk of excessive bleeding.
Career Highlights
Throughout her career, Dawn Bell has worked with prominent companies such as Chiesi Farmaceutici S.p.a. and The Medicines Company. Her work in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical treatments.
Collaborations
Dawn has collaborated with several professionals in her field, including Lisa Ruderman Chen and Simona Skerjanec. These collaborations have fostered a creative environment that has led to the development of impactful medical solutions.
Conclusion
Dawn Bell's innovative work in antiplatelet therapy exemplifies her commitment to improving patient outcomes. Her patents and collaborations highlight her significant role in the medical field, making her a valuable contributor to healthcare advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

